246 related articles for article (PubMed ID: 8909242)
1. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.
Woodman AC; Sugiyama M; Yoshida K; Sugino T; Borgya A; Goodison S; Matsumura Y; Tarin D
Am J Pathol; 1996 Nov; 149(5):1519-30. PubMed ID: 8909242
[TBL] [Abstract][Full Text] [Related]
2. Progressive loss of CD44 gene expression in invasive bladder cancer.
Sugino T; Gorham H; Yoshida K; Bolodeoku J; Nargund V; Cranston D; Goodison S; Tarin D
Am J Pathol; 1996 Sep; 149(3):873-82. PubMed ID: 8780391
[TBL] [Abstract][Full Text] [Related]
3. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
4. Changes in CD44 expression during carcinogenesis of the mouse colon.
Rudzki Z; LeDuy L; Jothy S
Exp Mol Pathol; 1997 Apr; 64(2):114-25. PubMed ID: 9316589
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the abnormal expression of CD44 gene and bladder cancer].
Wu Z; Zhang Y; Liu D
Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):645-7. PubMed ID: 9590747
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
An G; Ng AY; Meka CS; Luo G; Bright SP; Cazares L; Wright GL; Veltri RW
Cancer Res; 2000 Dec; 60(24):7014-20. PubMed ID: 11156405
[TBL] [Abstract][Full Text] [Related]
7. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 splice variants in bladder cancer.
Kan M; Furukawa A; Aki M; Kanayama H; Kagawa S
Int J Urol; 1995 Nov; 2(5):295-301. PubMed ID: 8749947
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 splice variants in colorectal cancer.
Wong LS; Cantrill JE; Morris AG; Fraser IA
Br J Surg; 1997 Mar; 84(3):363-7. PubMed ID: 9117309
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
Dehmel A; Becker M; Lemm M; Fichtner I
Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
12. Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
Aogi K; Kitahara K; Urquidi V; Tarin D; Goodison S
Clin Cancer Res; 1999 Oct; 5(10):2790-7. PubMed ID: 10537343
[TBL] [Abstract][Full Text] [Related]
13. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.
Goodison S; Yoshida K; Sugino T; Woodman A; Gorham H; Bolodeoku J; Kaufmann M; Tarin D
Cancer Res; 1997 Aug; 57(15):3140-4. PubMed ID: 9242440
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
Iczkowski KA; Bai S; Pantazis CG
Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
[TBL] [Abstract][Full Text] [Related]
15. Expression of adhesion molecule CD44 in metastatic brain tumors.
Harabin-Słowińska M; Słowiński J; Konecki J; Mrówka R
Folia Neuropathol; 1998; 36(3):179-84. PubMed ID: 9833394
[TBL] [Abstract][Full Text] [Related]
16. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.
Yoshida K; Sugino T; Bolodeoku J; Warren BF; Goodison S; Woodman A; Toge T; Tahara E; Tarin D
J Clin Pathol; 1996 Apr; 49(4):300-5. PubMed ID: 8655705
[TBL] [Abstract][Full Text] [Related]
17. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
[TBL] [Abstract][Full Text] [Related]
19. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities.
Matsumura Y; Sugiyama M; Matsumura S; Hayle AJ; Robinson P; Smith JC; Tarin D
J Pathol; 1995 Sep; 177(1):11-20. PubMed ID: 7472774
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
